Dr. Maricel M. Cubangbang

Dr. Patrick Ha is chief of the UCSF Division of Head and Neck Surgical Oncology. His expertise in patient care covers the full scope of head and neck surgery, with a focus on thyroid and parathyroid surgery as well as endoscopic approaches to throat cancer surgery. Ha's research is currently focused on molecular changes that occur in adenoid cystic carcinoma of the salivary gland. Ha received an undergraduate degree in biology from Harvard University, graduating magna cum laude. He obtained his medical degree from Johns Hopkins School of Medicine, graduating with membership in the Alpha Omega Alpha Honor Medical Society. He then completed his residency training and a postdoctoral fellowship at the otolaryngology department of Johns Hopkins, along with advanced fellowship training in head and neck oncologic surgery. Ha serves on the editorial board of several medical journals, including Oral Oncology. He is the Irwin Mark Jacobs and Joan Klein Jacobs Distinguished Professor in Head and Neck Cancer. Dr. Ha is highly rated in 20 conditions, according to our data. His clinical expertise encompasses Adenoid Cystic Carcinoma, Salivary Gland Tumors, Tongue Cancer, Gastrostomy, and Laryngectomy. Dr. Ha is board certified in American Board Of Otolaryngology, Otolaryngology. Dr. Ha is currently accepting new patients.

Dr. Ivan H. El-Sayed is a head and neck cancer surgeon. He specializes in treating benign and malignant lesions of the salivary glands, paranasal sinuses and skull base. El-Sayed's research interests include examining the value of sentinel node biopsy (a procedure to check whether cancer has spread) for head and neck cancer. He also is investigating potential uses of lasers and nanoparticles for diagnosing and treating cancer. El-Sayed earned his medical degree and completed a residency in otolaryngology at Boston University School of Medicine. He completed a fellowship in head and neck oncology at UCSF. Dr. El-Sayed is highly rated in 21 conditions, according to our data. His clinical expertise encompasses Olfactory Neuroblastoma, Sinus Cancer, Teratocarcinosarcoma, Endoscopy, and Turbinectomy. Dr. El-Sayed is board certified in American Board Of Otolaryngology, Otolaryngology. Dr. El-Sayed is currently accepting new patients.

Dr. Alain Algazi is a specialist in medical treatment – such as chemotherapy and immunotherapy – for patients with head and neck cancers, including head and neck squamous cell carcinoma, thyroid cancers and salivary gland cancers. He leads UCSF's program in medical therapy for head and neck cancers, and chairs the head and neck cancer research committee. In research, Algazi conducts clinical trials – studies that evaluate new therapies for head and neck cancers with an emphasis on approaches to improving the chances of long term remission in patients with incurable cancer using immunotherapy. He has also served the national study chair for clinical trials that give patients access to new medications and that provide new approaches of administering existing medications to improve their efficacy. Algazi earned his medical degree from the David Geffen School of Medicine at UCLA and completed a residency in internal medicine at Ronald Reagan UCLA Medical Center. He completed a fellowship in hematology-oncology at UCSF. Algazi is a member of the American Society of Clinical Oncology, Society for Immunotherapy for Cancer and American Association for Cancer Research. To reach Dr. Alain Algazi, please contact the head and neck medical oncology practice at (415) 353-9900. Dr. Algazi is highly rated in 21 conditions, according to our data. His clinical expertise encompasses Melanoma, Head and Neck Squamous Cell Carcinoma (HNSCC), Polymorphous Low Grade Adenocarcinoma, and Nasopharyngeal Carcinoma. Dr. Algazi is board certified in American Board Of Internal Medicine, Medical Oncology. Dr. Algazi is currently accepting new patients.